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ABSTRACT
SARS coronavirus (SARS-CoV) develops an antagonis-
tic mechanism by which to evade the antiviral activities
of interferon (IFN). Previous studies suggested that
SARS-CoV papain-like protease (PLpro) inhibits activa-
tion of the IRF3 pathway, which would normally elicit a
robust IFN response, but the mechanism(s) used by
SARS PLpro to inhibit activation of the IRF3 pathway is
not fully known. In this study, we uncovered a novel
mechanism that may explain how SARS PLpro efﬁ-
ciently inhibits activation of the IRF3 pathway. We found
that expression of the membrane-anchored PLpro
domain (PLpro-TM) from SARS-CoV inhibits STING/
TBK1/IKKε-mediated activation of type I IFNs and dis-
rupts the phosphorylation and dimerization of IRF3,
which are activated by STING and TBK1. Meanwhile, we
showed that PLpro-TM physically interacts with TRAF3,
TBK1, IKKε, STING, and IRF3, the key components that
assemble the STING-TRAF3-TBK1 complex for activa-
tion of IFN expression. However, the interaction between
the components in STING-TRAF3-TBK1 complex is dis-
rupted by PLpro-TM. Furthermore, SARS PLpro-TM
reduces the levels of ubiquitinated forms of RIG-I,
STING, TRAF3, TBK1, and IRF3 in the STING-TRAF3-
TBK1 complex. These results collectively point to a new
mechanism used by SARS-CoV through which PLpro
negatively regulates IRF3 activation by interaction with
STING-TRAF3-TBK1 complex, yielding a SARS-CoV
countermeasure against host innate immunity.
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interferon, deubiquitinase, STING-TRAF3-TBK1 complex
INTRODUCTION
The innate immune system represents the ﬁrst line of
defense and initiates counteractive responses that protect
the host from viral infection through evolutionarily conserved
pattern recognition receptors (PRR) (Kawai and Akira,
2007). PRRs include the membrane-bound Toll-like recep-
tors (TLRs) and cytosolic sensors, such as retinoic acid-
inducible gene-I (RIG-I)-like receptors (RLRs), which sense
RNA viruses (Kawai and Akira, 2007). RIG-I speciﬁcally
detects the intracellular double-stranded viral RNA bearing
5′ triphosphate and panhandle structures to activate antiviral
signaling (Hornung et al., 2006; Pichlmair et al., 2006). Once
a host is invaded by a virus, PRRs transmit signals to the
downstream kinases that activate transcription factors,
including IFN regulatory factor-3 (IRF3), nuclear factor κB
(NF-κB), and ATF-2/c-jun, with the help of different adaptor
molecules (MAVS/IPS-1/VISA/Cardif for RIG-I, TRIF for
TLR3, and MyD88 for TLR7/8/9) to activate IFN production
(Barral et al., 2009; Yoneyama and Fujita, 2009; Chen and
Jiang, 2013).
A previous study suggested that TRAF family members
are involved in the regulation of inﬂammation and antiviral
responses (Saha and Cheng, 2006). TRAF proteins play
signiﬁcant roles in signal transduction of antiviral innate
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immune responses. For example, TRAF3 uniquely regulates
the type I IFN response and speciﬁcally contributes to TBK1-
dependent IRF3 activation (Oganesyan et al., 2006; He
et al., 2007). TRAF3 stimulates the non-canonical IKK-rela-
ted kinase TBK1, which induces phosphorylation and
dimerization of IRF3, resulting in nuclear translocation and
activation of IRF3 (Fitzgerald et al., 2003). TRAF3 also
interacts with several key signaling molecules, such as
STING (stimulator of interferon genes, also known as MITA/
ERIS/MYPS), which resides at the ER/mitochondrial mem-
brane and forms dimers (Zhong et al., 2008; Sun et al.,
2009). TRAF3, STING, and TBK1 form a signaling complex
that transmits upstream sensory responses to downstream
effectors and then phosphorylates IRF3 to activate type I IFN
production.
Viruses have evolved elaborate mechanisms to evade or
inactivate the innate immune signaling pathway for their
replication (Schindler et al., 2007). Severe acute respiratory
syndrome (SARS) is a highly contagious respiratory disease
that appeared ﬁrst in China in 2002 and has infected more
than 8000 people worldwide and killed about 800 of those
infected. SARS coronavirus (SARS-CoV) has a single-
stranded, positive sense RNA genome of approximately 29.7
kb (Marra et al., 2003; Rota et al., 2003). Numerous studies
have revealed that SARS-CoV develops an antagonistic
mechanism to evade the antiviral activities of IFN (Devaraj
et al., 2007; Thiel and Weber, 2008; Perlman and Netland,
2009; Zielecki et al., 2013). Several studies have shown that
SARS-CoV papain-like protease (PLpro-TM) has deubiqui-
tination (DUB) activity. PLpro-TM serves as an IFN antago-
nist (Sulea et al., 2005; Barretto et al., 2006; Frieman et al.,
2009; Clementz et al., 2010). Previous reports have also
indicated that PLpro-TM inhibits the phosphorylation and
nuclear translocation of IRF3 (Devaraj et al., 2007; Frieman
et al., 2009). However, there are some discrepancies in how
PLpro-TM negatively regulates IRF3 activation. One study
reported that PLpro-TM interacts with IRF3 (Devaraj et al.,
2007). Another study rejected the ﬁnding that PLpro-TM has
any inﬂuence on the phosphorylation of IRF3 (Frieman et al.,
2009). A recent study has reported that PLP2 of mouse
hepatitis virus A59 targets TBK1 to negatively regulate type I
IFN by its DUB activity (Wang et al., 2011). It has also been
reported that M protein of SARS-CoV impedes the formation
of TRAF3-TBK1-IKKε complex and inhibits the production of
type I IFN (Siu et al., 2009). The mechanism or mechanisms
used by PLpro-TM to inhibit activation of the IRF3 pathway
are not fully understood.
In the current study, we found that SARS-CoV PLpro-TM
inhibits STING/TBK1/IKKε-mediated activation of type I IFN,
and disrupts the phosphorylation and dimerization of IRF3.
Furthermore, PLpro-TM interacts with STING, TRAF3, and
TBK1, and disrupts the interaction between the components
in STING-TRAF3-TBK1 complex that is required for the
activation of IRF3. PLpro-TM reduces the levels of ubiquiti-
nated forms of RIG-I, STING, TRAF3, TBK1, and IRF3, and
contributes to disruption of the signaling required for the
induction of IFN. Our work reveals a novel mechanism that
explains how SARS PLpro efﬁciently inhibits activation of the
IRF3 pathway, resulting in the SARS-CoV countermeasure
against host innate immunity.
RESULTS
PLpro-TM inhibits STING/TBK1/IKKε-mediated
activation of Type I interferon
Subsequent to our previous report that SARS coronavirus
PLpro negatively regulates IRF3-dependent innate immunity
(Devaraj et al., 2007), we determined to address whether
SARS PLpro-TM blocks STING/TBK1/IKKε-mediated acti-
vation of Type I IFN. In this study, we assessed the level of
STING/TBK1/IKKε-activated IFNβ- and IRF3- promoter
activities in the presence of SARS PLpro-TM. HEK293Tcells
were co-transfected with PLpro-TM and a combination of
plasmids encoding ﬁreﬂy luciferase under the control of IFN-
β promoter (Fig. 1A, 1C and 1E) or IRF3 promoter of PRD(III-
I)4 (Fig. 1B, 1D and 1F), and STING, TBK1, or IKKε as an
activator of the IFNβ signaling pathway. We found that the
stimulation of HEK-293T cells with STING alone increased
the activity of IFNβ- and IRF3- promoter more than 20-fold.
Co-expression of STING with SARS PLpro-TM resulted in a
signiﬁcant decrease in IFNβ- and IRF3- promoter activities,
indicating that SARS PLpro-TM can antagonize STING-
mediated activation of IFNβ- and IRF3- promoter activities
(Fig. 1A and 1B). SARS PLpro-TM signiﬁcantly inhibited
IFNβ- and IRF3- promoter activities, which are activated by
TBK1 (Fig. 1C and 1D) and IKKε (Fig. 1E and 1F). These
results indicate that SARS-CoV PLpro-TM antagonizes
STING/TBK1/IKKε-mediated IFN-β transcription by interfer-
ing with the activation of IRF3 pathway.
PLpro-TM antagonizes STING and TBK1-induced IRF3
activation
Since SARS-CoV PLpro-TM antagonizes STING/TBK1/
IKKε-mediated IFN-β transcription at the level of IRF3 acti-
vation, we examined whether PLpro-TM affects STING/
TBK1/IKKε induced dimerization and phosphorylation of
IRF3. HEK293T cells were co-transfected with HA-STING,
Flag-TBK1, or Flag-IKKε in the presence or absence of V5-
tagged PLpro-TM. We found that stimulation of HEK293T
cells with STING alone triggered the phosphorylation and
dimerization of IRF3 (Fig. 2A, lane 2). When co-transfected
with PLpro-TM, IRF3 dimer and phosphorylated IRF3 were
eliminated from the cells (Fig. 2A, lane 3). Overexpression of
TBK1 induced dimerization and phosphorylation of IRF3
(Fig. 2B, lane 2), but PLpro-TM signiﬁcantly reduced the
production of phosphorylated IRF3 and completely abol-
ished the dimerization of IRF3 (Fig. 2B, lane 3). SARS-CoV
PLpro-TM did not change the amount of IRF3 dimer or
phosphorylated IRF3, each of which was activated by IKKε
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(Fig. 2C, lanes 2 and 3). Thus, SARS-CoV PLpro-TM
inhibited STING- and TBK1-mediated dimerization and
phosphorylation of IRF3.
PLpro-TM interacts with STING-TRAF3-TBK1 complex
Because SARS PLpro-TM inhibited STING- and TBK1-
dependent activation of the IRF3 pathway, PLpro-TM might
associate with STING-TRAF3-TBK1 complex, either directly or
as part of the multiprotein complex. To conﬁrm this hypothesis,
we examined whether PLpro-TM interacted with the key sig-
naling components in the complex. Twenty-four hours after
transfection of HEK293Tcells with PLpro-TM and Flag-STING,
TRAF3,TBK1, or IKKε, the interactions betweenPLpro-TMand
these regulating proteins were assessed via co-immunopre-
cipitation and Western blotting. The interactions between
PLpro-TM and STING, TRAF3, TBK1, and IKKε were con-
ﬁrmed (Fig. 3A). The association between PLpro-TM and IRF3
was also identiﬁed (Fig. 3B). These results indicate that PLpro-
TM interacts with the STING-TRAF3-TBK1 complex.
Both PLpro-TM and STING are membrane-bound pro-
teins that are anchored to the endoplasmic reticulum (ER)
membrane with the transmembrane (TM) domain (Huang
et al., 2012; Ouyang et al., 2012; Shang et al., 2012; Shu
et al., 2012; Yin et al., 2012), and the TM domains at the
N-terminus of STING were found to be indispensable for
IRF3 activation in vitro (Tanaka and Chen, 2012). Our recent
study demonstrated that coronavirus PLpros negatively
regulate antiviral innate immune response by disruption of
STING-mediated signaling (Sun et al., 2012). In this study,
we further addressed which STING domains are required for






















































































































































Figure 1. SARS coronavirus PLpro-TM is a potent IFN antagonist. HEK293Tcells were co-transfected with either IFNβ-Luc (A, C,
E) or PRD (III-I) 4-Luc (B, D, F). The plasmids expressing HA-STING (A and B), Flag-TBK1 (C and D), or Flag-IKKε (E and F) were
applied to activate the IFN expression pathway and IRF3-dependent IFN expression pathway, in the presence or absence of PLpro-
TM-V5. pRL-TK encoding Rellina luciferase was applied for normalization of transfection efﬁciency. HEK293T cells were transfected
by Lipofectamine 2000 according to the manufacturer’s instructions and incubated for 24 h. The luciferase activities were assayed
with the Dual Luciferase Reporter Assay. The results were expressed as mean relative luciferase activity (ﬁreﬂy luciferase activity
divided by Renilla luciferase activity) including the standard deviation from repeated experiments carried out in triplicate. Asterisks
indicate statistical signiﬁcance (P < 0.05).
SARS PLpro disrupts STING-TRAF3-TBK1 complex RESEARCH ARTICLE









constructed a series of deletion mutants of STING, as
described in Fig. 3C. The association of STING mutants with
PLpro-TM was assessed by co-transfection of PLpro-TM
and each of the STING mutants into HEK293T cells. We
found that the association between STING and PLpro-TM
was completely abolished when 4 TM domains at the
N-terminus of STING were deleted (Fig. 3D, lanes 5 and 8).
Partial deletion of TM domains or the C-terminal helicase
domain did not affect the interaction between STING and
PLpro-TM (Fig. 3D, lanes 4, 6, and 7). These ﬁndings indi-
cate that PLpro-TM interacts with STING through the TM
domains.
PLpro-TM disrupts STING-TRAF3-TBK1 interaction
Because PLpro-TM interacts with the components of the
STING-TRAF3-TBK1 complex, we hypothesized that PLpro-
TM would impede the formation of functional STING-TRAF3-
TBK1 tripartite complex. To test this hypothesis, we asses-
sed the impacts of PLpro-TM on the assembly of the STING-
TRAF3-TBK1 complex. DNA plasmids expressing TRAF3,
MAVS, STING, and TBK1 were co-transfected into
HEK293Tcells in the absence and in the presence of PLpro-
TM. The cell lysate was co-immunoprecipitated (Fig. 4). We
observed that co-immunoprecipitation of TRAF3 with MAVS
or TBK1 was disrupted in the presence of PLpro-TM
(Fig. 4A, lane 4 and Fig. 4D, lane 3). The assembly of STING
with MAVS was obviously disrupted by PLpro-TM (Fig. 4B,
lane 3). We also found that PLpro-TM disrupted the co-
immunoprecipitation of STING with IRF3 (Fig. 4F, lane 3).
However, the expression of PLpro-TM had no effect on co-
immunoprecipitation of TRAF3 and STING (Fig. 4C, lane 3),
and the interaction of STING with TBK1 (Fig. 4E, lane 3).
Thus, SARS-CoV PLpro-TM disrupted the interaction
between the key components of STING-TRAF3-TBK1
complex, which explains how PLpro-TM suppresses the
activation and nuclear translocation of IRF3.
PLpro-TM blocks ubiquitination of STING-TRAF3-TBK1
complex
Multiple regulatory molecules located upstream of IRF3 in
the IFN pathway require ubiquitination, especially K63-linked
ubiquitination, and deubiquitination, which play critical roles
in the activation of IFN responses (Bibeau-Poirier and Ser-
vant, 2008; Bhoj and Chen, 2009; Isaacson and Ploegh,
2009; Zhong et al., 2010). Our team and others have pre-
viously reported that SARS PLpro-TM has DUB activity,
which acts as a negative regulator of the innate immune
response (Barretto et al., 2005; Lindner et al., 2005; Sulea
et al., 2005; Barretto et al., 2006; Ratia et al., 2006; Devaraj
et al., 2007; Chen et al., 2009; Frieman et al., 2009; Cle-
mentz et al., 2010; Sun et al., 2012). In the current study, we
examined whether SARS-CoV PLpro-TM could recognize
and deubiquitinate the key signaling molecules in the IFN
signaling pathway. HEK293T cells were co-transfected with
HA-Ub-K63 and plasmids which encode RIG-I, TRAF3,
STING, TBK1, or IRF3. The cell lysate was immunoprecipi-
tated to verify the ubiquitination status of those immuno-








































































Figure 2. PLpro-TM antagonizes STING and TBK1-induced IRF3 activation. HEK293T cells were mock transfected or
transfected PLpro-TM with HA-tagged STING (A), Flag-tagged TBK1 (B), or Flag-tagged IKKε (C) which was applied to activate IRF3
pathway. Proteins were extracted 24 h after transfection, the cell lysate was separated by Native PAGE followed by Western blotting
to detect IRF3 monomer and dimer forms (top of Fig. 2A–C). The expression of HA-STING, Flag-TBK1, Flag-IKKε, pIRF3, IRF3, and
PLpro-TM was analyzed by Western blotting performed with anti-HA, anti-Flag, anti-pIRF3, anti-IRF3, and anti-V5 antibodies,
respectively. Actin was detected from whole cell lysate (WCL) as a loading control (bottom of Fig. 2A–C). Each experiment was
repeated at least 3 times.
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poly-ubiquitinated RIG-I (Fig. 5A), TRAF3 (Fig. 5B), STING
(Fig. 5C), TBK1 (Fig. 5D), and IRF3 (Fig. 5E) in cells
expressing PLpro-TM. These ﬁndings indicated that PLpro-
TM inhibited the ubiquitination of RIG-I, TRAF3, STING,
TBK1, and IRF3 through its DUB activity. As ubiquitination of
these signaling regulators is required in the formation of
STING-TRAF3-TBK1, this result is in agreement with the
ﬁnding that SARS-CoV PLpro-TM blocks activation of IFN by
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Figure 3. PLpro-TM interacts with STING-TRAF3-TBK1 complex. (A) HEK293T cells were co-transfected with expression
plasmids for Flag-tagged STING, TBK1, IKKε, and TRAF3 both with and without PLpro-TM. The cell lysate was extracted 24 h after
transfection. Co-immunoprecipitation experiments were performed with the indicated antibodies. The co-immunoprecipitation product
was blotted by using anti-V5 (top panel), and re-probed by using anti-Flag (second panel) to detect TRAF3, TBK1, IKKε, and STING.
The input lysate was blotted by using anti-Flag to detect TRAF3, TBK1, IKKε, STING (third panel), and anti-V5 to detect PLpro-TM
(bottom panel). The asterisk indicates the nonspeciﬁc band. (B) HEK293T cells were transfected with Myc-tagged IRF3 in the
absence and in the presence of PLpro-TM. The cell lysate was extracted 24 h after transfection. Co-immunoprecipitation was
performed with the indicated antibodies. The co-immunoprecipitation product was blotted by using anti-V5 (top panel), and re-probed
by using anti-Myc (second panel) to detect IRF3. The input lysate was blotted using anti-V5 to detect PLpro-TM (third panel), and anti-
Myc to detect IRF3 (bottom panel). The asterisk indicates the nonspeciﬁc band. (C) Diagrams of full-length and truncated STING
proteins used in the study. TM, transmembrane domain. CT, C-terminus domain. (D) The association of PLpro-TM with HA-STING or
its truncated mutants. HEK293T cells were co-transfected with plasmids expressing HA-tagged STING or its truncated mutants, with
or without PLpro-TM. The cell lysate was extracted 24 h after transfection. Co-immunoprecipitation was performed with the indicated
antibodies. The co-immunoprecipitation product was blotted by using anti-V5 (top panel), and re-probed using anti-HA (second panel)
to detect STING and its truncated mutants. The input lysate was blotted by using anti-V5 to detect PLpro-TM (third panel), and anti-
HA to detect STING and its truncated mutants (bottom panel). The asterisk indicates the nonspeciﬁc band. Every experiment was
repeated for at least 3 times.
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SARS-CoV PLpro (PLpro-TM) acts as an IFN antagonist that
reduces the production of IFN by inhibiting activation of the
IRF3 pathway (Devaraj et al., 2007; Frieman et al., 2009;
Clementz et al., 2010; Sun et al., 2012), but the underlying
mechanisms used by SARS PLpro-TM to inhibit activation of
IRF3 pathway are not fully understood. In this study, we
uncovered a novel mechanism used by SARS PLpro-TM to
inhibit activation of the IRF3 pathway. We found that (1)
SARS-CoV PLpro-TM inhibits the activation of transcription
factor IRF3 and negatively modulates the IFNβ signaling
pathways, which results from PLpro-TM impeding STING-
and TBK1-activated phosphorylation and dimerization of
IRF3. (2) PLpro-TM interacts with TRAF3, TBK1, IKKε,
STING, and IRF3, the key components that assemble a
regulator complex for activation of IFN expression. However,
the interaction between the components in STING-TRAF3-
TBK1 complex is disrupted by PLpro-TM. (3) SARS PLpro-
TM reduces the levels of ubiquitinated forms of RIG-I,
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Figure 4. PLpro-TM disrupts the formation of STING-TRAF3-TBK1 complex. (A, B) HEK293T cells were transfected with Flag-
MAVS together with either HA-tagged TRAF3 (A) or HA-tagged STING (B) with or without PLpro-TM. Twenty-four hours after
transfection, the cell lysate was collected, and subjected to immunoprecipitation (IP) and immunoblotting (IB) using the indicated
antibodies. Co-immunoprecipitation was blotted using anti-Flag or anti-HA (Fig. 4A and 4B, top panels), and re-probed using anti-HA
or anti-Flag (Fig. 4A and 4B, second panels) for HA-TRAF3 (Fig. 4A) or Flag-MAVS (Fig. 4B). The input lysate was blotted using anti-
Flag or anti-HA to detect MAVS (Fig. 4A, third panel) or STING (Fig. 4B, third panel), and anti-V5 to detect PLpro-TM (Fig. 4A and 4B,
bottom panels). (C and D) HEK293T cells were co-transfected with HA-TRAF3 together with either Flag-tagged STING (C) or Flag-
tagged TBK1 (D) and PLpro-TM. Twenty-four hours after transfection, the cell lysate was prepared and subjected to
immunoprecipitation (IP) and immunoblotting (IB) with the indicated antibodies. (E and F) HA-STING and Flag-tagged TBK1
(E) or Myc-tagged IRF3 (F) were co-transfected into HEK293T cells with or without PLpro-TM. Twenty-four hours after transfection,
the cell lysate was collected and subjected to immunoprecipitation (IP) and immunoblotting (IB) with the indicated antibodies. Each
experiment was repeated at least 3 times.
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STING-TRAF3-TBK1 complex. These results revealed a
novel mechanism used by SARS coronavirus to negatively
regulate activation of innate immunity (Fig. 6).
The most striking ﬁnding of this study is that PLpro-TM
disrupts the STING-TRAF3-TBK1 complex, which leads to
inhibiting IRF3 activation. STING is important in regulating
the production of IFN (Ishikawa and Barber, 2008). STING
binds to both TBK1 and IRF3 and is necessary for the
activation of IRF3 (Tanaka and Chen, 2012). TRAF3 locates
at ER-to-Golgi transport compartments. Co-localization of
TRAF3 and STING allows them to be involved in the
induction of type I IFN innate immunity (van Zuylen et al.,
2012). TRAF3 binds to TBK1 and forms a complex with
TBK1, linking upstream signaling responses of RIG-I/Mda5-
MAVS-STING to the TBK1-directed phosphorylation of IRF3
and IFNβ transcription (Fig. 6A) (Fitzgerald et al., 2003;
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Figure 5. PLpro-TM reduces the ubiquitination levels of signaling molecules. The plasmids expressing Flag-tagged RIG-I (A),
TRAF3 (B), STING (C), TBK1 (D), and Myc-tagged IRF3 (E) together with HA-Ub-K63 were co-transfected into HEK293T cells in the
presence and in the absence of V5-tagged PLpro-TM. Cells were incubated for 24 h after transfection and treated with 25 μmol/L
MG132 for 4 h prior to the harvest of the cell lysate. The cell lysate was immunoprecipitated with the indicated antibodies. The
products were immunoblotted using anti-HA to evaluate K63-linked ubiquitinated proteins (upper panels). The whole cell lysate
(WCL) was blotted to evaluate the expression of PLpro-TM (bottom panels). Each experiment was repeated at least 3 times. The
asterisk indicates the nonspeciﬁc band from cellular proteins with high afﬁnity with Agarose.
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Oganesyan et al., 2006). In this study, we showed that
SARS-CoV PLpro-TM interacts with the components of
STING-TRAF3-TBK1 complex, and that PLpro-TM inhibits
formation of the STING-TRAF3-TBK1 complex that is nec-
essary for IFNβ transcription. PLpro-TM also disrupts the
interaction between these key signaling proteins and pre-
vents STING-TRAF3-TBK1 complex from activating IRF3
(Fig. 6B). We conﬁrm that SARS PLpro-TM interacts with
STING, a recently identiﬁed regulator that facilitates the
recruitment of TBK1. This is in agreement with our recent
ﬁnding that NL63 CoV PLP2 disrupts the dimerization of
STING and deubiquitinates STING for modulation of IFN
expression (Sun et al., 2012). Along with our previous ﬁnd-
ings, this study revealed a new mechanism that PLpro-TM
interacts with STING by disruption of the STING-TRAF3-
TBK1 complex, which leads to inhibiting IRF3 activation. Our
ﬁndings suggest that SARS coronavirus PLpro-TM interacts
with STING through the TM domain at the N-terminus of
STING. STING forms a membrane trafﬁcking system that
mediates the dynamic translocation of STING and leads to
the effective induction of innate immune responses (Saitoh
et al., 2010), but the interaction between PLpro-TM and
STING prohibits the membrane trafﬁcking of STING, which
results in inhibition of phosphorylation and dimerization of
IRF3 and blocks IFN signaling transduction (Fig. 6B).
Ubiquitination and deubiquitination emerge as the key
mechanisms that regulate the virus-induced type I IFN sig-
naling pathways (Bibeau-Poirier and Servant, 2008; Bhoj
and Chen, 2009; Isaacson and Ploegh, 2009; Zhong et al.,
2010). Ubiquitination, especially K63-linked ubiquitination, is
critically involved in regulation of the activation of related
receptors, such as RIG-I, and transduction of cell signaling
pathways in innate immune responses (Zeng et al., 2010). In
contrast, deubiquitination inhibits the activation of signaling
molecules, and cellular and viral DUBs play important roles
in negative regulation of host innate immunity. A20, named
after its cDNA clone No. and also referred to as tumor
necrosis factor α-induced protein (TNFAIP) 3, has DUB
activity that is a central gatekeeper in inﬂammation and
immunity. It removes K-63 linked poly-ubiquitin chains from
RIP1, TRAF6, RIP2, and NEMO and negatively regulates
the innate immune responses (Coornaert et al., 2009). Cel-
lular protein DUBA speciﬁcally deubiquitinates TRAF3 that is




































Figure 6. A hypothetical model depicting the mechanisms used by SARS-CoV PLpro-TM to disrupt the STING-TRAF3-TBK1
complex required for activation of the IFN-β production pathway. (A) Viral infections are sensed by pattern-recognition receptors
(PRRs), which in turn recognize pathogen-associated molecular patterns (PAMPs) and trigger antiviral responses. RIG-I identiﬁes the
5′-3p RNA, and then interacts with MAVS to activate the IFN responses factor 3 (IRF3). In MAMs (mitochondrial-associated
membranes), MAVS also interacts with STING that locates at the ER (endoplasmic reticulum), and induces the ubiquitination and
dimerization of STING. The activated STING recruits TBK1 and IRF3 and contributes to the phosphorylation of IRF3 mediated by
TBK1. STING recruits TBK1 and IKKε and forms the TBK1-IKKε complex via the association with TRAF3. The TBK1 complex induces
the phosphorylation, dimerization, and nuclear translocation of IRF3. (B) When SARS-CoV invades the host, these processes are
disrupted by SARS-CoV PLpro-TM. PLpro-TM disrupts activation of the IRF3 pathway induced by STING-TRAF3-TBK1 by blocking
the assembly of the complex, and it deubiquitinates the signaling molecules RIG-I, TRAF3, STING, TBK1, and IRF3.
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phosphorylation of IRF3 (Kayagaki et al., 2007; Wang et al.,
2011). Recent studies revealed that coronaviruses, including
human CoV NL63, MHV, and SARS-CoV, have evolved to
encode DUBs for modulating the innate immunity (Barretto
et al., 2005; Sulea et al., 2005; Chen et al., 2007; Frieman
et al., 2009; Clementz et al., 2010; Wang et al., 2011; Sun
et al., 2012). We have reported that human CoV NL63
reduces the ubiquitinated forms of STING, RIG-I, TBK1, and
IRF3 to negatively regulate IFN signaling (Sun et al., 2012).
MHV-A59 PLP2 distinctively targets and deubiquitinates
TBK1 to negatively regulate cellular type I IFN signaling
pathway (Wang et al., 2011). DUBs have been reported in
other viral proteins, such as arterivirus EAV PLP2 (van
Kasteren et al., 2013), herpes simplex virus type 1 (HSV-1)
UL36 (Kattenhorn et al., 2005), and porcine reproductive and
respiratory syndrome virus (PRRSV) nsp2 (Chen et al.,
2010; Sun et al., 2010). These viral proteins act as IFN
antagonists through the DUB activity.
Multiple SARS coronaviral proteins, such as ORF3b,
ORF6, N, M, and nsp1, have been suggested to inhibit IFN
production (Kamitani et al., 2006; Devaraj et al., 2007; Fri-
eman et al., 2007; Kopecky-Bromberg et al., 2007; Wathelet
et al., 2007; Zust et al., 2007; Narayanan et al., 2008; Siu
et al., 2009). SARS M protein is associated with TRAF3,
which is crucial for the IFN responses and impairs the
function of TRAF3-TBK1-IKKε (Siu et al., 2009). The for-
mation of TRAF3-TBK1 complex is an essential step in the
activation of IRF3 (Siu et al., 2009). We found in thestudy
that when TRAF3 and TBK1 were co-expressed in HEK293T
cells, the interaction between TRAF3 and TBK1 was
observed in cells. However, the interaction between TRAF3
and TBK1 was completely disrupted in the presence of
PLpro-TM. Furthermore, the interaction between STING and
TBK1 was signiﬁcantly decreased when coexpressed with
PLpro-TM. These data collectively indicate that PLpro-TM
impeded the interactions between the components of
STING-TRAF3-TBK1 complex, which results in inhibition of
the activation of IRF3. There are differences between M
protein and PLpro-TM in the regulation of IRF3 activation.
SARS M protein inhibits the activation of IRF3 mediated by
both TBK1 and IKKε (Siu et al., 2009). When IKKε and
PLpro-TM were co-expressed in HEK293T cells, we found
that SARS-CoV PLpro-TM did not inhibit IKKε-mediated
phosphorylation and dimerization of IRF3. However, IKKε
activation of the IRF3-dependent IFNβ-Luc and PRD (III-I)4-
Luc reporters is obviously inhibited by PLpro-TM. This dis-
crepancy may be due to one or more other mechanisms
explaining how PLpro blocks IKKε-mediated ubiquitination
and translocation of IRF3. Additionally, the Gn cytoplasmic
tail of Hantavirus forms a complex with TRAF3 that disrupts
the formation of TBK1-TRAF3 complexes and their down-
stream signaling responses required for IFNβ transcription
(Alff et al., 2008; Matthys and Mackow, 2012). This may be a
common mechanism used by human viruses to regulate
antiviral innate immunity by preventing formation of the
STING-TRAF3-TBK1 complex.
In summary, our ﬁndings uncover a new mechanism used
by SARS-CoV through which PLpro-TM negatively regulates
IFN activation, as depicted in Fig. 6. SARS PLpro-TM blocks:
1) STING and TBK1-medaited phosphorylation and dimer-
ization of IRF3; 2) the STING-TRAF3-TBK1 complex for-
mation; and 3) the ubiquitination of the key signaling
molecules in the IFNβ expression pathway, such as STING,
TRAF3, TBK1, and IRF3. Our study has yielded strong evi-
dence of the mechanisms underlying SARS-CoV counter-
measures against host innate immunity.
MATERIALS AND METHODS
Cell culture, transfection reagent, and antibodies
HEK 293T cells were cultured in Dulbecco’s Modiﬁed Eagle’s Med-
ium (GIBCO) supplemented with 10% heat-inactivated fetal bovine
serum (FBS) and maintained at 37°C in a humidiﬁed 5% CO2
incubator. Transient transfection reagent Lipofectamine 2000 was
purchased from Invitrogen. Anti-HA (MBL), anti-Flag (MBL), anti-V5
(MBL), anti-Myc (MBL), anti-β-Actin (Beyotime), anti-IRF3 (Abcam),
and anti-pIRF3 (Abcam) antibodies were used in the study.
Plasmid DNAs
The wild-type SARS-CoV PLpro-TM, which containing PLpro core
domain (aa 1541 to 1855 and the TM domain (aa 2139–2425), and
plasmids of IFN-β-Luc, PRD (III-I) 4-Luc, and HA-tagged Ub-K63
were previously described (Devaraj et al., 2007; Clementz et al.,
2010). Constructs of Flag-MAVS, Myc-IRF3, Flag-TBK1, Flag-RIG-I,
and Flag-RIG-IN were kindly provided by Dr. Himanshu Kuma and
Shizuo Akira (Immunology Frontier Research Center, Osaka Uni-
versity, Osaka, Japan). Flag-STING, HA-STING, and Flag-IKKε
were kindly provided by Dr. Zhengfan Jiang (School of Life Sci-
ences, Peking University, Beijing, China) and Dr. Xuemin Zhang
(National Biomedicine Center, Beijing). HA-TRAF3 and Flag-TRAF3
plasmids were kindly supplied by Dr. Kui Li (University of Tennessee,
Memphis, Tennessee, USA).
Construction of STING deletion mutants
A series of STING mutants were constructed as shown in Fig. 3C.
Brieﬂy, STING mutants were ampliﬁed by PCR or overlap PCR from
HA-STING construct, and inserted into pCMV-HA vector with a HA
tag at the N-terminus of each STING mutant. The forward (P1) pri-
mer and reverse primer (P2) for each mutant were as follows:
STINGΔCT P1: 5′-CGGAATTCCGCCCCACTCCAGCCTGCATCCA
TCCC-3′, STINGΔCT P2: 5′-CCGCTCAGAGTCAGAGCTCTGGCA
GGATCAGCCG-3′. STINGΔSP P1: 5′-CGGAATTCCGGCAGCCTT
GGTTCTGCTGAGTGCC-3′, STINGΔSP P2: 5′-CCGCTCGAGTCA
AGAGAAATCCGTGCGGAGAGG-3′. STINGΔNT P1: 5′-CGGAATT
CCGCAGGCCCGGATTCGAACTTACATTC-3′, STINGΔNT P2: 5′-
CCGCTCGAGTCAAGAGAAATCCGTGCGGAGAGG-3′. STINGΔ1–
2 P1: 5′-GTGAAGGGCGGGCCGACCGCCTTCTGGGCCCCGTGA
CCCC-3′, STINGΔ1–2 P2: 5′-GCGGTCGGCCCGCCCTTCAC-3′.
SARS PLpro disrupts STING-TRAF3-TBK1 complex RESEARCH ARTICLE










CAGACCCCGTTTAA C-3′, STINGΔ3–4 P2: 5′-CAGGCCCGGATTC
GAACTTAC-3′. STINGΔ1–4 P1: 5′-TAAGTTCGAATCCGGGCCTGC
TTCTGGGCCCCGTGACCCC-3′, Δ1–4 P2: 5′-CAGGCCCGGATTC
GAACTTAC-3′. PCRs were performed with LA Taq (TaKaRa) for the
initial denaturation at 94°C for 5 min, then 30 cycles of 94°C for 30 s,
55°C for 30 s, and 72°C for 60 s, and extension at 72°C for 60 s. For
some of the STING mutants, overlap PCR was performed. During
the ﬁrst-round PCR, 2 small fragments were ampliﬁed with the use of
HA-STING as a template for the initial denaturation at 94°C for 5
min, then 30 cycles of 94°C for 30 s, 55°C for 30 s, and 72°C for 60
s, and extensions at 72°C for 10 min. The amplicons were puriﬁed
and fused together by 5 cycles of 94°C for 30 s, 55°C for 30 s, and
72°C for 60 s, and extensions at 72°C for 10 min, followed by 25
cycles of 94°C for 30 s, 55°C for 30 s, and 72°C for 60 s, and
extensions at 72°C for 10 min. All the STING deletion mutants were
cloned into pCMV-HA vector and conﬁrmed by endonuclease
digestion analysis and DNA sequencing.
Luciferase assay
HEK293T cells were transfected with the reporter plasmid DNAs
(pRL-TK, IFN-β-Luc, or PRD (III-I) 4-Luc, the IRF3 promoter con-
trolled Luciferase reporter, and SARS PLpro-TM) using Lipofect-
amine 2000 according to the manufacturer’s protocol and incubated
for 24 h. Fireﬂy luciferase and Renilla luciferase activities were
assayed using the Dual Luciferase Reporter Assay Kit (Promega).
The results were expressed as mean values of the relative luciferase
activity (ﬁreﬂy luciferase activity divided by Renilla luciferase activity)
including the standard deviation from repeated experiments carried
out in triplicate. For statistical analysis, differences between the
values of regulators and regulators co-transfected with PLpro-TM
were subjected to unpaired, 2-tailed Student’s t test performed with
the use of Microsoft SPSS 12.0 software. A P value of <0.05 was
considered statistically signiﬁcant (Vaux et al., 2012).
Western blotting analysis
HEK 293T cells were seeded in 60-mm-diameter dishes and incu-
bated at 37°C for 18 h. The cells were subsequently transfected with
SARS PLpro-TM or empty vector using Lipofectamine 2000 reagent
according to the manufacturer’s instruction. Twenty-four hours after
transfection, cells were lysed in RIPA buffer, containing protease
inhibitor cocktail at 4°C for 30 min, spun down at 12,000 rpm for 10
min. Protein extracts in 40 μL of 2× SDS-PAGE sample buffer were
boiled for 10 min. Samples were separated on SDS-PAGE gel and
transferred to NC membrane. Blots were incubated with indicated
primary antibodies. After 3 washings in 1× TBS-T buffer, blots were
incubated with HRP-conjugated secondary antibodies (Beyotime,
China). Antibody-antigen reactions were detected with the use of
Western Lighting Plus-ECL chemiluminescence reagents (Biomed,
China). Each experiment was repeated at least 3 times.
IRF3 dimer detection
To assess IRF3 dimerization, HEK293T cells were transfected with
HA-STING or Flag-TBK1/IKKε (1 μg) in the presence and in the
absence of V5-tagged PLpro-TM (1 μg). Twenty-four hours after
transfection, the cell lysate was fractionated by 8% Native Gel in
running buffer containing 1% sodium deoxycholate at 4°C, as pre-
viously described (Frieman et al., 2009). After electrophoresis, pro-
teins were transferred and analyzed by Western blotting with the
indicated antibodies. Each experiment was repeated at least 3 times.
Co-immunoprecipitation (Co-IP) analysis
The effects of SARS PLpro-TM in disrupting the interaction between
STING and associated proteins in cultured cells were assessed as
previously described (Gack et al., 2007). Brieﬂy, HEK293Tcells were
co-transfected with Flag/HA-STING (2 μg), Flag-TRAF3 (2 μg), Flag-
TBK1/IKKε/MAVS (2 μg), and Myc-IRF3 (2 μg) in the presence and in
the absence of V5-tagged PLpro-TM (2 μg) with the use of Lipofect-
amine 2000. Twenty-four hours later, cells were lysed in RIPA buffer
(50 mmol/L Tris-HCl pH 7.4, 150 mmol/L NaCl, 2 mmol/L EDTA, 1%
NP-40) containing protease inhibitor cocktail (1mmol/L, Roche), 0.1%
SDS, and 10 μmol/L NEM at 4°C for 30 min. The cell extracts were
then spun down at 12,000 rpm for 10 min at 4°C. The soluble lysate
was immunoprecipitated with anti-Flag/HA antibody for at least 12 h,
the lysatewas then precleared by the addition of 40μL of protein A +G
agrose (Beyotime) and rocked at 4°C for 6 h. This was followed by
spinning down the beads. The bead-antibody-protein complex was
spun down and washed 4 times with 1 mL RIPA buffer or PBS. The
protein was eluted from the beads in 40 μL of 2× SDS-PAGE sample
buffer subjected to boiling for 10 min. The proteins were separated by
SDS-PAGE and transferred to NC membrane for Western blotting.
Each experiment was repeated at least 3 times.
Assessing ubiquitination of signaling molecules
The effect of SARS PLpro-TM on ubiquitinated proteins in cultured
cells was assessed as previously described (Evans et al., 2004;
Clementz et al., 2010). Brieﬂy, Flag-tagged RIG-I, TRAF3, STING,
TBK1, IKKε, and Myc-tagged IRF3 (1.0 μg each) were co-transfec-
ted into HEK293T cells cultured in 60-mm dishes together with
pcDNA3.1-HA-Ub-K63. Transfection was performed with Lipofect-
amine 2000 according to the manufacturer’s instructions. Empty
vector pcDNA3.1/V5-HisB was used to standardize the total amount
of DNA used for transfection. After 24 h, cells were incubated with 25
μmol/L MG132 for 4 h, then harvested by the addition of 300 μL
RIPA buffer (50 mmol/L Tris-HCl pH 7.4, 150 mmol/L NaCl, 2 mmol/L
EDTA, 1% NP-40) containing protease inhibitor cocktail (1 mmol/L,
Roche), 0.1% SDS, and 10 μmol/L NEM at 4°C for 30 min, spun
down at 12,000 rpm for 10 min. Non-covalently bound proteins were
dissociated by boiling the lysate in 1% SDS; samples were diluted
1:10 in lysis buffer (50 mmol/L Tris-HCl pH 7.4, 150 mmol/L NaCl, 2
mmol/L EDTA, 1% NP-40) containing protease inhibitor cocktail and
10 μmol/L NEM. The soluble lysate was then immunoprecipitated
with anti-Flag/HA antibody for at least 12 h, the lysate was then
precleared by adding 40 μL protein A + G agrose (Beyotime) and
rocked at 4°C for 6 h, followed by spinning down the beads. The
beads-antibody-protein complex was spun down and washed 4
times with 1 mL RIPA buffer or PBS. The protein was eluted from the
beads in 40 μL of 2× SDS-PAGE sample buffer subjected to boiling
for 10 min. The samples were separated by SDS-PAGE and trans-
ferred to NC membrane for Western blotting. Each experiment was
repeated at least 3 times.
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NEMO, NF-κB essential modulator; NF-κB, nuclear factor κB;
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severe acute respiratory syndrome coronavirus; STING, stimulator
of interferon genes; TBK1, TANK-binding kinase 1; TLRs, Toll-like
receptors; TM, transmembrane; PLpro-TM, the membrane-anchored
PLpro domain; TRAF, tumor necrosis factor receptor-associated
factor; PRD, positive regulatory domain.
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